Medicine and Dentistry
Cardiovascular Disease
100%
Apoplexy
96%
Health System
96%
Myocardial Infarction
82%
Cardiovascular System
75%
Maturity Onset Diabetes of the Young
71%
Low Density Lipoprotein Cholesterol
66%
Brain Ischemia
59%
Odds Ratio
59%
Electronic Health Record
58%
Statin
57%
COVID-19
57%
Heart Failure
46%
Patient with Type 2 Diabetes
45%
Mortality Rate
41%
Secondary Prevention
40%
Cerebral Hemorrhage
38%
Percutaneous Aortic Valve Replacement
38%
Blood Pressure
38%
Antithrombotic
38%
Lipoprotein
38%
Diabetes
36%
Hospital Mortality
34%
Revascularization
32%
Sodium Glucose Cotransporter 2 Inhibitor
28%
Cardiovascular Risk
26%
Retrospective Cohort Study
26%
Systolic Blood Pressure
25%
Drug Therapy
24%
Primary Health Care
23%
Atrial Fibrillation
22%
Epileptic Absence
22%
Severe Acute Respiratory Syndrome Coronavirus 2
21%
Combination Therapy
21%
Shared Decision Making
21%
Primary Prevention
21%
Randomized Clinical Trial
20%
Simulation Center
19%
Computer Assisted Tomography
19%
Heart Surgery
19%
Risk Reduction
19%
Cardiogenic Shock
19%
Congestive Heart Failure
19%
Pressure Control
19%
Immunoglobulin G Antibody
19%
Telemedicine
19%
G Protein Coupled Receptor
19%
Coronavirus Infection
19%
Sudden Cardiac Death
19%
Gynecology
19%
Coronary Artery
19%
Vitamin K Antagonist
19%
Translational Research
19%
Medicine
19%
Tissue Plasminogen Activator
19%
Isotopes of Calcium
19%
Anesthesiology
19%
Enzyme Linked Immunosorbent Assay
19%
Receptor
19%
Quality Improvement
19%
Disease Surveillance
19%
Patient with Diabetes
19%
GM1 Gangliosidosis
19%
Alteplase
19%
Acute Heart Infarction
19%
Direct Oral Anticoagulant
19%
Urology
19%
Percutaneous Thrombectomy
19%
Case Definition
19%
Antiplatelet
19%
Implantable Automatic Defibrillator
19%
Apolipoprotein B
19%
Oxidoreductase
19%
Internal Fixation
19%
Open Reduction (Procedure)
19%
Distal Radius Fracture
19%
Postoperative Care
19%
Outpatient
17%
Coronary Artery Disease
16%
Disease
15%
Risk Stratification
15%
Logistic Regression Analysis
15%
Diastolic Blood Pressure
14%
Social Determinants of Health
14%
Race Difference
14%
Anticoagulant
13%
Ezetimibe
12%
Androstanolone
12%
Proprotein Convertase 9
10%
Medicare
10%
Health Care
9%
General Medicine
9%
Glycemic Control
9%
Endocrinology
9%
Cardiology
9%
Catheterization
9%
Nephrology
9%
Renal Protection
9%
Stenosis
9%
Telangiectasia
9%
Keyphrases
Atherosclerotic Cardiovascular Disease (ASCVD)
77%
United States
66%
Lipid-lowering Therapy
61%
Acute Ischemic Stroke
59%
Community Practice
59%
Patients with Diabetes
59%
COVID-19
57%
Type 2 Diabetes Mellitus (T2DM)
54%
Health Systems
52%
Adjusted Odds Ratio
51%
Myocardial Infarction
51%
Cardiovascular Disease
49%
Clinical Outcomes
49%
Low-density Lipoprotein Cholesterol (LDL-C)
42%
Heart Failure
42%
Older Adults
41%
Secondary Prevention
40%
30-day Readmission
38%
COVID-19 Pandemic
38%
Intracranial Hemorrhage
38%
Out-of-pocket Expenditure
38%
Cardiovascular Events
35%
Statins
28%
Hypertension
27%
Clinical Practice
27%
High-intensity Statin
27%
Risk Prediction
26%
Retrospective Cohort Study
26%
Odds Ratio
26%
Electronic Health Records
25%
Heart Failure Hospitalization
24%
Confidence Interval
23%
Randomized Clinical Trial
22%
Risk Score
22%
Non-statins
22%
Primary Prevention
21%
Non-vitamin K Antagonist Oral Anticoagulants
21%
Black Men
21%
Stroke Prevention
20%
Patients with Heart Failure
20%
Pre-stroke
20%
Clinical Care
20%
Ischemic Stroke
20%
Computed Tomography
19%
Risk Assessment
19%
Pheromone Control
19%
Incremental Value
19%
Copay
19%
Vouchers
19%
Cardiac Inflammation
19%
Actual Risk
19%
National Variation
19%
Automated ELISA
19%
EHR Data
19%
Aspirin Therapy
19%
Atrial Fibrillation
19%
Guideline Comparison
19%
Anticoagulant Use
19%
Antiplatelet Treatment
19%
Patients at Risk
19%
Cardiac Remodeling
19%
Glucagon-like peptide-1 (GLP-1)
19%
Complete Revascularization
19%
Recurrent Cardiovascular Events
19%
Receptor Agonist
19%
Incidental
19%
Blood Pressure Control
19%
Angiographic Features
19%
Patients with Cardiovascular Diseases
19%
Post-infarct Heart Failure
19%
Telemedicine
19%
Familiar Hypercholesterolemia
19%
Mitochondrial Metabolites
19%
Door-to-needle Time
19%
Improved Outcomes
19%
Coronavirus Infections
19%
Readmission Risk
19%
Diabetes Disease
19%
Hospitalized Patients
19%
Racial Stratification
19%
Tissue Plasminogen Activator (t-PA)
19%
Cardioverter-defibrillator Implantation
19%
Vitamin K Antagonists
19%
Treatment Efficacy
19%
Antithrombotic Therapy
19%
Topological Inversion
19%
Sudden Cardiac Death
19%
Incident Event
19%
Adverse Cardiovascular Events
19%
Cardiac Surgery Hospital
19%
Lipoproteins
19%
Coronary Artery Calcium Score
19%
Coronary Artery Calcium
19%
Disease Surveillance
19%
Cohort Analysis
19%
Daple
19%
Medical Approach
19%
GM1 Gangliosidosis
19%
Direct Oral Anticoagulants
19%
Endovascular Thrombectomy
19%